DOJ to investigate Google’s $2.1B acquisition of Fitbit

The Department of Justice will probe Google’s $2.1 billion acquisition of wearables company Fitbit, The New York Post reported, citing a source close to the situation.

Google’s parent company, Alphabet, announced plans to acquire Fitbit in November. The DOJ has been cleared to review the proposed acquisition, following a tussle between federal law enforcement and the Federal Trade Commission, which is also seeking authority to investigate the deal, the NY Post reported. Only one antitrust agency reviews a merger after proposals are filed to both the DOJ and FTC.

The merger reviews stem from a concern of Google holding too much private data of users, including health information. The DOJ is already investigating Google for other anti-trust reasons.

Google’s ongoing collaboration with Ascension Health, in which Google receives the health information of tens of millions of patients, is also under scrutiny by HHS.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.